David Mulham Mulham - 06 Feb 2024 Form 4 Insider Report for USANA HEALTH SCIENCES INC (USNA)

Role
CHIEF SALES OFFICER
Signature
/s/ Joshua Foukas, Attorney-in-Fact
Issuer symbol
USNA
Transactions as of
06 Feb 2024
Net transactions value
$0
Form type
4
Filing time
08 Feb 2024, 18:43:55 UTC
Previous filing
06 Feb 2024
Next filing
12 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction USNA Common Stock Options Exercise +2,377 +36% 8,904 06 Feb 2024 Direct F1
transaction USNA Common Stock Options Exercise +1,556 +17% 10,460 07 Feb 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction USNA Restricted Stock Units Options Exercise $0 -2,377 -14% $0.000000 15,153 06 Feb 2024 Common Stock 2,377 Direct F1, F2
transaction USNA Restricted Stock Units Options Exercise $0 -1,556 -10% $0.000000 13,597 07 Feb 2024 Common Stock 1,556 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
F2 Restricted Stock Units vest 25% on the anniversary of February 6th, 2023.
F3 Restricted Stock Units vest 25% on the anniversary of February 7th, 2022.